Literature DB >> 7564223

Liver transplantation in tyrosinaemia type I: the Groningen experience.

F A Wijburg1, W C Reitsma, M J Slooff, F J van Spronsen, H A Koetse, D J Reijngoud, G P Smit, R Berger, C M Bijleveld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7564223     DOI： 10.1007/BF00711743

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  7 in total

Review 1.  Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.

Authors:  F J van Spronsen; R Berger; G P Smit; J B de Klerk; M Duran; C M Bijleveld; H van Faassen; M J Slooff; H S Heymans
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Hereditary tyrosinemia type I: a new clinical classification with difference in prognosis on dietary treatment.

Authors:  F J van Spronsen; Y Thomasse; G P Smit; J V Leonard; P T Clayton; V Fidler; R Berger; H S Heymans
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

3.  Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.

Authors:  D H Van Thiel; L M Gartner; F K Thorp; S L Newman; J A Lindahl; E Stoner; M I New; T E Starzl
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

4.  Surgical and metabolic aspects of liver transplantation for tyrosinemia.

Authors:  F I Luks; D St-Vil; B J Hancock; J M Laberge; A L Bensoussan; P Russo; G Mitchell; M Lambert; H Blanchard
Journal:  Transplantation       Date:  1993-12       Impact factor: 4.939

5.  Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.

Authors:  S Lindstedt; E Holme; E A Lock; O Hjalmarson; B Strandvik
Journal:  Lancet       Date:  1992-10-03       Impact factor: 79.321

6.  Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.

Authors:  A Salt; N D Barnes; K Rolles; R Y Calne; P T Clayton; J V Leonard
Journal:  Acta Paediatr       Date:  1992-05       Impact factor: 2.299

7.  Orthotopic liver transplantation, Epstein-Barr virus, cyclosporine, and lymphoproliferative disease: a growing concern.

Authors:  J F Malatack; J C Gartner; A H Urbach; B J Zitelli
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406
  7 in total
  3 in total

1.  Screening for tyrosinaemia type I.

Authors:  A C Hutchesson; S K Hall; M A Preece; A Green
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-05       Impact factor: 5.747

2.  Tyrosinaemia type I: considerations of treatment strategy and experiences with risk assessment, diet and transplantation.

Authors:  F J van Spronsen; G P Smit; F A Wijburg; Y Thomasse; G Visser; H S Heymans
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Revisiting bupropion anti-inflammatory action: involvement of the TLR2/TLR4 and JAK2/STAT3.

Authors:  Alireza Karimollah; Anahid Hemmatpur; Taha Vahid
Journal:  Inflammopharmacology       Date:  2021-07-03       Impact factor: 4.473
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.